The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain

Clinical trial NCT00376454 · COMPLETED

Trial details

NCT number: NCT00376454
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuropathic Pain

Start date: 2002-11-01
Primary completion: 2003-06-01
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.